Stuck in traffic: An emerging theme in diseases of the nervous system

Trends in Neurosciences

Volumn 37, Issue 2, 2014, Pages 66-76

  Neefjes, Jacques ^a   van der Kant, Rik ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyothoropic lateral sclerosis; Charcot Marie Tooth disease; Endo lysosomal system; Hereditary spastic paraplegia; Neurological disease; Parkinson's disease; Protein trafficking

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID PRECURSOR PROTEIN; DYNEIN ADENOSINE TRIPHOSPHATASE; ESCRT PROTEIN; GUANOSINE TRIPHOSPHATASE; KINESIN 1; LEUCINE RICH REPEAT KINASE 2; LYSOSOME ENZYME; MEMBRANE PROTEIN; MOLECULAR MOTOR; NERVE GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; PRESENILIN 1; RAB PROTEIN; RAB7 PROTEIN; SORTING NEXIN; WNT PROTEIN;

ACTIN FILAMENT; ALZHEIMER DISEASE; CALCIUM HOMEOSTASIS; CELL MIGRATION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENDOSOME; GENE MUTATION; GOLGI COMPLEX; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUNTINGTON CHOREA; INTELLECTUAL IMPAIRMENT; INTRACELLULAR TRANSPORT; LIPOFUSCINOSIS; LYSOSOME; MICROTUBULE; MOTONEURON; MOTOR NEURON DISEASE; MULTIVESICULAR BODY; NERVE FIBER GROWTH; NEUROLOGIC DISEASE; NEUROPATHY; NIEMANN PICK DISEASE; NONHUMAN; PERRY SYNDROME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TARGETING; REVIEW; SPINAL MUSCULAR ATROPHY;

ALZHEIMER'S DISEASE; AMYOTHOROPIC LATERAL SCLEROSIS; CHARCOT-MARIE-TOOTH DISEASE; ENDO-LYSOSOMAL SYSTEM; HEREDITARY SPASTIC PARAPLEGIA; NEUROLOGICAL DISEASE; PARKINSON'S DISEASE; PROTEIN TRAFFICKING;

ANIMALS; HUMANS; NERVOUS SYSTEM DISEASES; PROTEIN TRANSPORT;

EID: 84893639063     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2013.11.006     Document Type: Review

References (126)

1. Huotari J., Helenius A. Endosome maturation. EMBO J. 2011, 30:3481-3500.
2. Basu R., Chang F. Shaping the actin cytoskeleton using microtubule tips. Curr. Opin. Cell Biol. 2007, 19:88-94.
3. Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 2009, 10:513-525.
4. Jovic M., et al. The early endosome: a busy sorting station for proteins at the crossroads. Histol. Histopathol. 2010, 25:99-112.
5. Pal A., et al. Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease. J. Cell Biol. 2006, 172:605-618.
6. Caviston J.P., Holzbaur E.L. Huntingtin as an essential integrator of intracellular vesicular trafficking. Trends Cell Biol. 2009, 19:147-155.
7. Kawauchi T., et al. Rab GTPases-dependent endocytic pathways regulate neuronal migration and maturation through N-cadherin trafficking. Neuron 2010, 67:588-602.
8. Wucherpfennig T.M., et al. Role of Drosophila Rab5 during endosomal trafficking at the synapse and evoked neurotransmitter release. J. Cell Biol. 2003, 161:609-624.
9. Satoh D., et al. Spatial control of branching within dendritic arbors by dynein-dependent transport of Rab5-endosomes. Nat. Cell Biol. 2010, 10:1164-1171.
10. Yang Y., et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet. 2001, 29:160-165.
11. Li Q., et al. Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity. J. Biol. Chem. 2011, 286:40151-40162.
12. Schmieg N., et al. Signalling endosomes in axonal transport: Travel updates on the molecular highway. Semin. Cell Dev. Biol. 2013, pii: S1084-9521(13)00109-2. 10.1016/j.semcdb.2013.10.004.
13. Jean S., et al. Sbf/MTMR13 coordinates PI(3)P and Rab21 regulation in endocytic control of cellular remodeling. Mol. Biol. Cell 2012, 23:2723-2740.
14. Robinson F.L., et al. Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:4916-4921.
15. Mottola G., et al. A novel function for the Rab5 effector Rabenosyn-5 in planar cell polarity. Development 2010, 137:2353-2364.
16. Lu H., Bilder D. Endocytic control of epithelial polarity and proliferation in Drosophila. Nat. Cell Biol. 2005, 7:1232-1239.
17. Pietiainen V., et al. NDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation. J. Cell Sci. 2013, 126:3961-3971.
18. Cataldo A.M., et al. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 2000, 157:277-286.
19. Israel M.A., et al. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 2012, 482:216-220.
20. Deinhardt K., et al. Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron 2006, 52:293-305.
21. Johansson M., et al. Activation of endosomal dynein motors by stepwise assembly of Rab7-RILP-p150Glued, ORP1L, and the receptor betalll spectrin. J. Cell Biol. 2007, 176:459-471.
22. Cantalupo G., et al. Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes. EMBO J. 2001, 20:683-693.
23. Jordens I., et al. The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors. Curr. Biol. 2001, 11:1680-1685.
24. van der Kant R., et al. Late endosomal transport and tethering are coupled processes controlled by RILP and the cholesterol sensor ORP1L. J. Cell Sci. 2013, 126:3462-3474.
25. Rocha N., et al. Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endosome positioning. J. Cell Biol. 2009, 185:1209-1225.
26. Rosa-Ferreira C., Munro S. Arl8 and SKIP act together to link lysosomes to kinesin-1. Dev. Cell 2011, 21:1171-1178.
27. Garg S., et al. Lysosomal trafficking, antigen presentation, and microbial killing are controlled by the Arf-like GTPase Arl8b. Immunity 2011, 35:182-193.
28. Kamal A., et al. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 2001, 414:643-648.
29. Fernandez-Monreal M., et al. The balance between receptor recycling and trafficking toward lysosomes determines synaptic strength during long-term depression. J. Neurosci. 2012, 32:13200-13205.
30. Verhoeven K., et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am. J. Hum. Genet. 2003, 72:722-727.
31. Spinosa M.R., et al. Functional characterization of Rab7 mutant proteins associated with Charcot-Marie-Tooth type 2B disease. J. Neurosci. 2008, 28:1640-1648.
32. McCray B.A., et al. Disease mutations in Rab7 result in unregulated nucleotide exchange and inappropriate activation. Hum. Mol. Genet. 2010, 19:1033-1047.
33. Cogli L., et al. CMT2B-associated Rab7 mutants inhibit neurite outgrowth. Acta Neuropathol. 2010, 120:491-501.
34. Zhang K., et al. Defective axonal transport of Rab7 GTPase results in dysregulated trophic signaling. J. Neurosci. 2013, 33:7451-7462.
35. Puls I., et al. Mutant dynactin in motor neuron disease. Nat. Genet. 2003, 33:455-456.
36. Poirier K., et al. Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly. Nat. Genet. 2013, 45:639-647.
37. Harms M.B., et al. Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy. Neurology 2012, 78:1714-1720.
38. Bird T.D., et al. Charcot-Marie-Tooth neuropathy type 2. GeneReviews 1993, University of Washington. R.A. Pagon (Ed.).
39. Neveling K., et al. Mutations in BICD2, which encodes a golgin and important motor adaptor, cause congenital autosomal-dominant spinal muscular atrophy. Am. J. Hum. Genet. 2013, 92:946-954.
40. Oates E.C., et al. Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia. Am. J. Hum. Genet. 2013, 92:965-973.
41. Peeters K., et al. Molecular defects in the motor adaptor BICD2 cause proximal spinal muscular atrophy with autosomal-dominant inheritance. Am. J. Hum. Genet. 2013, 92:955-964.
42. Schiavo G., et al. Cytoplasmic dynein heavy chain: the servant of many masters. Trends Neurosci. 2013, 36:641-651.
43. Farrer M.J., et al. DCTN1 mutations in Perry syndrome. Nat. Genet. 2009, 41:163-165.
44. Xu B., et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat. Genet. 2012, 44:1365-1369.
45. Gissen P., et al. Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome. Nat. Genet. 2004, 36:400-404.
46. Cullinane A.R., et al. Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization. Nat. Genet. 2010, 42:303-312.
47. Abu-Sa'da O., et al. Arthrogryposis, renal tubular acidosis and cholestasis (ARC) syndrome: two new cases and review. Clin. Dysmorphol. 2005, 14:191-196.
48. Mizushima N., et al. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
49. Matsui T.N., et al. The Rab interacting lysosomal protein (RILP) homology domain functions as a novel effector domain for small GTPase Rab36: Rab36 regulates retrograde melanosome transport in melanocytes. J. Biol. Chem. 2012, 287:28619-28631.
50. Chen L., et al. Rab36 regulates the spatial distribution of late endosomes and lysosomes through a similar mechanism to Rab34. Mol. Membr. Biol. 2010, 27:24-31.
51. Piccione M., et al. The first case of myoclonic epilepsy in a child with a de novo 22q11.2 microduplication. Am. J. Med. Genet. A 2011, 155A:3054-3059.
52. Zhao C., et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 2001, 105:587-597.
53. Matsushita M., et al. A novel kinesin-like protein, KIF1Bbeta3 is involved in the movement of lysosomes to the cell periphery in non-neuronal cells. Traffic 2004, 5:140-1451.
54. Schnitzer M.J., Block S.M. Kinesin hydrolyses one ATP per 8nm step. Nature 1997, 388:386-390.
55. Hua W., et al. Coupling of kinesin steps to ATP hydrolysis. Nature 1997, 388:390-393.
56. Funfschilling U., et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 2012, 485:517-521.
57. Zala D., et al. Vesicular glycolysis provides on-board energy for fast axonal transport. Cell 2013, 152:479-491.
58. Caviston J.P., et al. Huntingtin facilitates dynein/dynactin-mediated vesicle transport. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:10045-10050.
59. Li S.H., et al. Interaction of huntingtin-associated protein with dynactin P150Glued. J. Neurosci. 1998, 18:1261-1269.
60. Engelender S., et al. Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum. Mol. Genet. 1997, 6:2205-22012.
61. Rong J., et al. Regulation of intracellular trafficking of huntingtin-associated protein-1 is critical for TrkA protein levels and neurite outgrowth. J. Neurosci. 2006, 26:6019-6030.
62. Henne W.M., et al. The ESCRT pathway. Dev. Cell 2011, 21:77-91.
63. Skibinski G., et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 2005, 37:806-808.
64. Latour P., et al. SIMPLE mutation analysis in dominant demyelinating Charcot-Marie-Tooth disease: three novel mutations. J. Peripher. Nerv. Syst. 2006, 11:148-155.
65. Saifi G.M., et al. SIMPLE mutations in Charcot-Marie-Tooth disease and the potential role of its protein product in protein degradation. Hum. Mutat. 2005, 25:372-383.
66. Bennett C.L., et al. SIMPLE mutation in demyelinating neuropathy and distribution in sciatic nerve. Ann. Neurol. 2004, 55:713-720.
67. Lee S.M., et al. Mutations associated with Charcot-Marie-Tooth disease cause SIMPLE protein mislocalization and degradation by the proteasome and aggresome-autophagy pathways. J. Cell Sci. 2011, 124:3319-3331.
68. Lee S.M., et al. Charcot-Marie-Tooth disease-linked protein SIMPLE functions with the ESCRT machinery in endosomal trafficking. J. Cell Biol. 2012, 199:799-816.
69. Chow C.Y., et al. Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 2007, 448:68-72.
70. Bolino A., et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet. 2000, 25:17-19.
71. Franklin N.E., et al. Endosomal targeting of the phosphoinositide 3-phosphatase MTMR2 is regulated by an N-terminal phosphorylation site. J. Biol. Chem. 2011, 286:15841-15853.
72. Seaman M.N. The retromer complex - endosomal protein recycling and beyond. J. Cell Sci. 2012, 125:4693-4702.
73. Bonifacino J.S., Hierro A. Transport according to GARP: receiving retrograde cargo at the trans-Golgi network. Trends Cell Biol. 2011, 21:159-167.
74. Vilarino-Guell C., et al. VPS35 mutations in Parkinson disease. Am. J. Hum. Genet. 2011, 89:162-167.
75. Zimprich A., et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet. 2011, 89:168-175.
76. Andersson E.R., et al. Wnt5a cooperates with canonical Wnts to generate midbrain dopaminergic neurons in vivo and in stem cells. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:E602-E610.
77. Zhang D., et al. RAB-6.2 and the retromer regulate glutamate receptor recycling through a retrograde pathway. J. Cell Biol. 2012, 196:85-101.
78. Villar V.A., et al. Novel role of sorting nexin 5 in renal D(1) dopamine receptor trafficking and function: implications for hypertension. FASEB J. 2013, 27:1808-1819.
79. Ahmed S., et al. Disease-associated mutations in the p150(Glued) subunit destabilize the CAP-gly domain. Biochemistry 2010, 49:5083-5085.
80. MacLeod D.A., et al. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron 2013, 77:425-439.
81. Valdmanis P.N., et al. Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia. Am. J. Hum. Genet. 2007, 80:152-161.
82. Ropers F., et al. Identification of a novel candidate gene for non-syndromic autosomal recessive intellectual disability: the WASH complex member SWIP. Hum. Mol. Genet. 2011, 20:2585-2590.
83. Perez-Victoria F.J., et al. Structural basis for the wobbler mouse neurodegenerative disorder caused by mutation in the Vps54 subunit of the GARP complex. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12860-21285.
84. Infante R.E., et al. NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:15287-15292.
85. Du X., et al. A role for oxysterol-binding protein-related protein 5 in endosomal cholesterol trafficking. J. Cell Biol. 2011, 192:121-135.
86. Mukherjee S., Maxfield F.R. Lipid and cholesterol trafficking in NPC. Biochim. Biophys. Acta 2004, 1685:28-37.
87. Neufeld E.B., et al. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease. J. Biol. Chem. 2004, 279:15571-15578.
88. Lonka L., et al. The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum. Hum. Mol. Genet. 2000, 9:1691-1697.
89. Passantino R., et al. Identifying protein partners of CLN8, an ER-resident protein involved in neuronal ceroid lipofuscinosis. Biochim. Biophys. Acta 2013, 1833:529-540.
90. Teuling E., et al. Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J. Neurosci. 2007, 27:9801-9815.
91. Sidransky E., et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N. Engl. J. Med. 2009, 361:1651-1661.
92. Uusi-Rauva K., et al. Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments. Cell. Mol. Life Sci. 2012, 69:2075-2089.
93. Pearce D.A., et al. Action of BTN1, the yeast orthologue of the gene mutated in Batten disease. Nat. Genet. 1999, 22:55-58.
94. Getty A.L., Pearce D.A. Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function. Cell. Mol. Life Sci. 2011, 68:453-474.
95. Mamo A., et al. The role of ceroid lipofuscinosis neuronal protein 5 (CLN5) in endosomal sorting. Mol. Cell. Biol. 2012, 32:1855-1866.
96. Verheijen F.W., et al. A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nat. Genet. 1999, 23:462-465.
97. Town M., et al. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat. Genet. 1998, 18:319-324.
98. LaPlante J.M., et al. Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway. FEBS Lett. 2002, 532:183-187.
99. Van Deerlin V.M., et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet. 2010, 42:234-239.
100. Wheeler R.B., et al. A new locus for variant late infantile neuronal ceroid lipofuscinosis-CLN7. Mol. Genet. Metab. 1999, 66:337-338.
101. Lasiecka Z.M., Winckler B. Mechanisms of polarized membrane trafficking in neurons - focusing in on endosomes. Mol. Cell. Neurosci. 2011, 48:278-287.
102. Yap C.C., Winckler B. Harnessing the power of the endosome to regulate neural development. Neuron 2012, 74:440-451.
103. Twelvetrees A., et al. SnapShot: axonal transport. Cell 2012, 149:950.
104. Overly C.C., Hollenbeck P.J. Dynamic organization of endocytic pathways in axons of cultured sympathetic neurons. J. Neurosci. 1996, 16:6056-6064.
105. Kelly E.E., et al. The role of endosomal-recycling in long-term potentiation. Cell. Mol. Life Sci. 2011, 68:185-194.
106. Ibanez C.F. Message in a bottle: long-range retrograde signaling in the nervous system. Trends Cell Biol. 2007, 17:519-528.
107. Delcroix J.D., et al. NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals. Neuron 2003, 39:69-84.
108. Erlich Y., et al. Exome sequencing and disease-network analysis of a single family implicate a mutation in KIF1A in hereditary spastic paraparesis. Genome Res. 2011, 21:658-664.
109. Tsang H.T., et al. The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling. Hum. Mol. Genet. 2009, 18:3805-3821.
110. Cataldo A.M., et al. Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects. Am. J. Pathol. 2008, 173:370-384.
111. Ginsberg S.D., et al. Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease. J. Alzheimers Dis. 2010, 22:631-639.
112. Lee J.H., et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 2010, 141:1146-1158.
113. Zhang X., et al. A role for presenilins in autophagy revisited: normal acidification of lysosomes in cells lacking PSEN1 and PSEN2. J. Neurosci. 2012, 32:8633-8648.
114. Coen K., et al. Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells. J. Cell Biol. 2012, 198:23-35.
115. Rajendran L., Annaert W. Membrane trafficking pathways in Alzheimer's disease. Traffic 2012, 13:759-770.
116. Morris M., et al. The many faces of tau. Neuron 2011, 70:410-4126.
117. Hanein S., et al. Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome. Am. J. Hum. Genet. 2008, 82:992-1002.
118. Sagona A.P., et al. PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody. Nat. Cell Biol. 2010, 12:362-371.
119. Furuta A., et al. Lysosomal storage and advanced senescence in the brain of LAMP-2-deficient Danon disease. Acta Neuropathol. 2013, 125:459-461.
120. Hirst J., et al. Adaptor protein complexes AP-4 and AP-5: new players in endosomal trafficking and progressive spastic paraplegia. Traffic 2013, 14:153-164.
121. O'Brien J.S., Kishimoto Y. Saposin proteins: structure, function, and role in human lysosomal storage disorders. FASEB J. 1991, 5:301-308.
122. Sandhoff K., Harzer K. Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis. J. Neurosci. 2013, 33:10195-10208.
123. Ouyang Q., et al. Christianson syndrome protein NHE6 modulates TrkB endosomal signaling required for neuronal circuit development. Neuron 2013, 80:97-112.
124. Dehay B., et al. Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:9611-9616.
125. Bird T.D., et al. Charcot-Marie-Tooth neuropathy type 1. GeneReviews 1993, University of Washington. R.A. Pagon (Ed.).
126. Kawamura N., et al. Delivery of endosomes to lysosomes via microautophagy in the visceral endoderm of mouse embryos. Nat. Commun. 2012, 3:1071.